Polymorphisms within inflammatory genes and colorectal cancer

Journal of Negative Results in BioMedicine

Volumn 5, Issue , 2006, Pages

  Landi, Stefano ^a,f,h   Gemignani, Federica ^a   Bottari, Fabio ^a   Gioia Patricola, Lydie ^b   Guino, Elisabet ^c   Cambray, María ^c   Biondo, Sebastiano ^d,f   Capella, Gabriel ^c   Boldrini, Laura ^e,g   Canzian, Federico ^h   Moreno, Victor ^c,d,f  

^a UNIVERSITY OF PISA   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e UNIVERSITY HOSPITAL OF PISA   (Italy)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g UNIVERSITY OF PISA   (Italy)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12A; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC ANALYSIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; POLYMORPHISM, GENETIC;

EID: 33750839061     PISSN: 14775751     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-5-15     Document Type: Article

References (28)

1. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002, 420:860-867.
2. Phoa N, Epe B: Influence of nitric oxide on the generation and repair of oxidative DNA damage in mammalian cells. Carcinogenesis 2002, 23:469-475.
3. Jackson AL, Loeb LA: The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001, 477:7-21.
4. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD: The codependence of angiogenesis and chronic inflammation. FASEB J 1997, 11:457-465.
5. Moore MA: Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing. J Cell Biochem Suppl 2002, 38:29-38.
6. Nakajima N, Kuwayama H, Ito Y, Iwasaki A, Arakawa Y: Helicobacter pylori, neutrophils, interleukins, and gastric epithelial proliferation. J Clin Gastroenterol 1997, 25(Suppl 1):S198-202.
7. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 107:1183-1188.
8. Itzkowitz SH, Yio X: Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004, 287:G7-17.
9. Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, de Oca J, Capella G, Canzian F, Bellvitge Colorectal Cancer Study Group: Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 2003, 63:3560-3566.
10. Leung TF, Tang NL, Wong GW, Fok TF: CD14 and toll-like receptors: potential contribution of genetic factors and mechanisms to inflammation and allergy. Curr Drug Targets Inflamm Allergy 2005, 4:169-175.
11. Schroder NW, Schumann RR: Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005, 5:156-164.
12. Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC: CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart 2004, 90:983-988.
13. Rovin BH, Lu L, Saxena R: A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999, 259:344-348.
14. Becker C, Wirtz S, Neurath MF: Stepwise regulation of TH1 responses in autoimmunity: IL-12-related cytokines and their receptors. Inflamm Bowel Dis 2005, 11:755-764.
15. Yilmaz V, Yentur SP, Saruhan-Direskeneli G: IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005, 30:188-194.
16. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H: Protective role of endothelial nitric oxide synthase. J Pathol 2003, 199:8-17.
17. Wallace JL, Miller MJ: Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 2000, 119:512-520.
18. Perner A, Rask-Madsen J: Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders. Aliment Pharmacol Ther 1999, 13:135-144.
19. [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191160].
20. [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=153440].
21. Pfeffer K: Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 2003, 14:185-191.
22. Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, Lynch NJ, MacPherson AJ, Bridger S, van Deventer S, Stokkers P, Morin P, Mirza MM, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S: Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 1999, 65:1647-1655.
23. Spahn TW, Herbst H, Rennert PD, Lugering N, Maaser C, Kraft M, Fontana A, Weiner HL, Domschke W, Kucharzik T: Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches. Am J Pathol 2002, 161:2273-2282.
24. Jones R, Adel-Alvarez LA, Alvarez OR, Broaddus R, Das S: Arachidonic acid and colorectal carcinogenesis. Mol Cell Biochem 2003, 253:141-149.
25. Romano M, Claria J: Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J 2003, 17:1986-1995.
26. IARC: Non steroidal anti-inflammatory drugs. IARC Handbooks of Cancer Prevention. Volume 1. Lyon France: IARC Press; 1997.
27. Byrne MF, Murphy JF, Corcoran PA, Atherton JC, Sheehan KM, Cox D, Murray FE, Fitzgerald DJ: Helicobacter pylori induces cyclooxygenase-1 and cyclooxygenase-2 expression in vascular endothelial cells. Scand J Gastroenterol 2003, 38:1023-1030.
28. Cox DG, Pontes C, Guino E, Navarro M, Osorio A, Canzian F, Moreno V, Bellvitge Colorectal Cancer Study Group: Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br J Cancer 2004, 91:339-343.